(2024). EXPRESSION OF CONCERN: Rosiglitazone and 15‐deoxy‐Δ 12,14 ‐prostaglandin J 2 , ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion injury of the gut. Wiley. https://doi.org/10.1111/bph.17421
Chicago Style (17th ed.) CitationEXPRESSION OF CONCERN: Rosiglitazone and 15‐deoxy‐Δ 12,14 ‐prostaglandin J 2 , Ligands of the Peroxisome Proliferator‐activated Receptor‐γ (PPAR‐γ), Reduce Ischaemia/reperfusion Injury of the Gut. Wiley, 2024. https://doi.org/10.1111/bph.17421.
MLA (9th ed.) CitationEXPRESSION OF CONCERN: Rosiglitazone and 15‐deoxy‐Δ 12,14 ‐prostaglandin J 2 , Ligands of the Peroxisome Proliferator‐activated Receptor‐γ (PPAR‐γ), Reduce Ischaemia/reperfusion Injury of the Gut. Wiley, 2024. https://doi.org/10.1111/bph.17421.